FDA stem cell oversight at risk as clinics to ask SCOTUS to weigh in
The U.S. Supreme Court could soon have a historic opportunity to limit the scope of FDA stem cell oversight. A large stem cell clinic firm now says it plans to ask SCOTUS to review a case it recently lost on appeal to the FDA. If SCOTUS takes the case, the FDA could find its powers […]
FDA stem cell oversight at risk as clinics to ask SCOTUS to weigh in Read More »